Jane Winter
Affiliations: | Northwestern University, Evanston, IL |
Area:
Chemical EngineeringGoogle:
"Jane Winter"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Paudel N, Schulze D, Gentzler RD, et al. (2019) Patterns of Failure and Survival Outcomes After Total Lymphoid Irradiation and High-Dose Chemotherapy With Autologous Stem Cell Transplantation for Relapsed or Refractory Classical Hodgkin Lymphoma. International Journal of Radiation Oncology, Biology, Physics |
| Al-Mansour Z, Li H, Cook JR, et al. (2019) Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis. Leukemia & Lymphoma. 1-8 |
| Puvvada SD, Stiff PJ, Leblanc M, et al. (2016) Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704. British Journal of Haematology |
| Yap TA, Johnson PWM, Winter J, et al. (2016) A phase I, open-label study of GSK2816126, an enhancer of zeste homolog 2 (EZH2) inhibitor, in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), transformed follicular lymphoma (tFL), other non-Hodgkin’s lymphomas (NHL), multiple myeloma (MM) and solid tumor. Journal of Clinical Oncology. 34 |
| Nelson BP, Abdul-Nabi A, Goolsby C, et al. (2014) Characterization of tissue findings in bone marrow biopsy specimens with small monoclonal B-cell populations. American Journal of Clinical Pathology. 141: 687-96 |
| Gentzler RD, Evens AM, Rademaker AW, et al. (2014) F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma. British Journal of Haematology. 165: 793-800 |
| Stiff PJ, Unger JM, Cook JR, et al. (2013) Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma. The New England Journal of Medicine. 369: 1681-90 |
| Vidula N, Jovanovic B, Winter J, et al. (2012) Early and Late Complications Associated with Busulfan, Cyclophosphamide, and Etoposide (Bu/Cy/VP-16) Conditioning Followed by Allogeneic or Autologous Stem Cell Transplantation in Relapsed/Refractory Non-Hodgkin'S Lymphoma Biology of Blood and Marrow Transplantation. 18 |
| Williams ME, Dreyling M, Winter J, et al. (2010) Management of mantle cell lymphoma: key challenges and next steps. Clinical Lymphoma, Myeloma & Leukemia. 10: 336-46 |
| Evens AM, David KA, Helenowski I, et al. (2010) Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 1038-46 |